Phillip D. Zamore
72Patents
23h-index
32Co-inventors
88Inventor score
Filing activity: Jul 12, 2002 → Jan 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7691995B2 | In vivo production of small interfering RNAS that mediate gene silencing | Chemistry; Metallurgy | 245 | Expired |
| US7459547B2 | Methods and compositions for controlling efficacy of RNA silencing | Emerging Cross-Sectional Technologies | 168 | Expired |
| US7750144B2 | Methods and compositions for enhancing the efficacy and specificity of RNA silencing | Chemistry; Metallurgy | 149 | Active |
| US9217155B2 | Isolation of novel AAV'S and uses thereof | Chemistry; Metallurgy | 100 | Active |
| US7772203B2 | Methods and compositions for controlling efficacy of RNA silencing | Emerging Cross-Sectional Technologies | 98 | Active |
| US7732593B2 | Methods and compositions for controlling efficacy of RNA silencing | Emerging Cross-Sectional Technologies | 84 | Active |
| US8309705B2 | Methods and compositions for enhancing the efficacy and specificity of RNA silencing | Chemistry; Metallurgy | 67 | Active |
| US8329892B2 | Methods and compositions for enhancing the efficacy and specificity of RNA silencing | Chemistry; Metallurgy | 66 | Active |
| US8304530B2 | Methods and compositions for enhancing the efficacy and specificity of RNA silencing | Chemistry; Metallurgy | 65 | Active |
| US8309704B2 | Methods and compositions for enhancing the efficacy and specificity of RNAi | Chemistry; Metallurgy | 62 | Expired |
| US9596835B2 | Isolation of novel AAV's and uses thereof | Chemistry; Metallurgy | 59 | Active |
| US8420391B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 59 | Active |
| US8552171B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 52 | Active |
| US9193753B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 50 | Active |
| US8790922B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 50 | Active |
| US8632997B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 46 | Active |
| US8729036B2 | Compositions for RNA interference and methods of use thereof | Chemistry; Metallurgy | 40 | Active |
| US9012138B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 37 | Active |
| US9012621B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 37 | Active |
| US9272053B2 | AAV-based treatment of cholesterol-related disorders | Chemistry; Metallurgy | 31 | Active |
| US8394628B2 | RNA sequence-specific mediators of RNA interference | Chemistry; Metallurgy | 29 | Active |
| US7947658B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 26 | Expired |
| US8680063B2 | RNA interference for the treatment of gain-of-function disorders | Chemistry; Metallurgy | 26 | Active |
| US8987222B2 | Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease | Chemistry; Metallurgy | 23 | Active |
| US10300146B2 | Isolation of novel AAV's and uses thereof | Chemistry; Metallurgy | 23 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.